Cargando…

Insights into new-onset autoimmune diseases after COVID-19 vaccination

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ming, Liu, Xiaoxiao, Chen, Xiangmei, Li, Qinggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/
https://www.ncbi.nlm.nih.gov/pubmed/37075917
http://dx.doi.org/10.1016/j.autrev.2023.103340
_version_ 1785026874341064704
author Guo, Ming
Liu, Xiaoxiao
Chen, Xiangmei
Li, Qinggang
author_facet Guo, Ming
Liu, Xiaoxiao
Chen, Xiangmei
Li, Qinggang
author_sort Guo, Ming
collection PubMed
description Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the epidemic. Currently, the SARS-CoV-2 Omicron variant has rapidly become globally dominant in the COVID-19 pandemic due to its high infectivity and immune evasion. Consequently, vaccination implementation is critically significant. However, growing evidence suggests that COVID-19 vaccination may cause new-onset autoimmune diseases, including autoimmune glomerulonephritis, autoimmune rheumatic diseases, and autoimmune hepatitis. Nevertheless, the causal relationship between COVID-19 vaccines and these autoimmune diseases remains to be demonstrated. In this review, we provide evidence that vaccination induces autoimmunity and summarize possible mechanisms of action, such as molecular mimicry, activation by bystanders, and adjuvants. Our objective is not to refute the importance of vaccines, but to raise awareness about the potential risks of COVID-19 vaccination. In fact, we believe that the benefits of vaccination far outweigh the possible risks and encourage people to get vaccinated.
format Online
Article
Text
id pubmed-10108562
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-101085622023-04-18 Insights into new-onset autoimmune diseases after COVID-19 vaccination Guo, Ming Liu, Xiaoxiao Chen, Xiangmei Li, Qinggang Autoimmun Rev Article Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the epidemic. Currently, the SARS-CoV-2 Omicron variant has rapidly become globally dominant in the COVID-19 pandemic due to its high infectivity and immune evasion. Consequently, vaccination implementation is critically significant. However, growing evidence suggests that COVID-19 vaccination may cause new-onset autoimmune diseases, including autoimmune glomerulonephritis, autoimmune rheumatic diseases, and autoimmune hepatitis. Nevertheless, the causal relationship between COVID-19 vaccines and these autoimmune diseases remains to be demonstrated. In this review, we provide evidence that vaccination induces autoimmunity and summarize possible mechanisms of action, such as molecular mimicry, activation by bystanders, and adjuvants. Our objective is not to refute the importance of vaccines, but to raise awareness about the potential risks of COVID-19 vaccination. In fact, we believe that the benefits of vaccination far outweigh the possible risks and encourage people to get vaccinated. Elsevier B.V. 2023-07 2023-04-17 /pmc/articles/PMC10108562/ /pubmed/37075917 http://dx.doi.org/10.1016/j.autrev.2023.103340 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Guo, Ming
Liu, Xiaoxiao
Chen, Xiangmei
Li, Qinggang
Insights into new-onset autoimmune diseases after COVID-19 vaccination
title Insights into new-onset autoimmune diseases after COVID-19 vaccination
title_full Insights into new-onset autoimmune diseases after COVID-19 vaccination
title_fullStr Insights into new-onset autoimmune diseases after COVID-19 vaccination
title_full_unstemmed Insights into new-onset autoimmune diseases after COVID-19 vaccination
title_short Insights into new-onset autoimmune diseases after COVID-19 vaccination
title_sort insights into new-onset autoimmune diseases after covid-19 vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/
https://www.ncbi.nlm.nih.gov/pubmed/37075917
http://dx.doi.org/10.1016/j.autrev.2023.103340
work_keys_str_mv AT guoming insightsintonewonsetautoimmunediseasesaftercovid19vaccination
AT liuxiaoxiao insightsintonewonsetautoimmunediseasesaftercovid19vaccination
AT chenxiangmei insightsintonewonsetautoimmunediseasesaftercovid19vaccination
AT liqinggang insightsintonewonsetautoimmunediseasesaftercovid19vaccination